Epifanova M.V.
Chalyi M.E.
Gvasaliya B.R.
Eremin I.I.
Pulin A.A.
Nadelyaeva I.I.
Artemenko S.A.
Galitskaya D.A.
Repin A.M.
Research Institute for Uronephrology and Human Reproductive Health, Moscow, Russia.
Department of Urology, I.M. Sechenov First MSMU, Moscow, Russia.
The 3rd A.A. Vishnevsky Central Military Clinical Hospital of Ministry of Defense of Russia, Moscow, Russia.
Institute of General Pathology and Pathophysiology, Moscow, Russia.
Central State Medical Academy, Moscow, Russia.
New approaches for recovery of erectile function in patients after radical prostatectomy
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 6 С. 138-143
2017
adipose tissue stem cells
autologous platelet-rich plasma
cell therapy
erectile dysfunction
mesenchymal stem cells
prostate cancer
radical prostatectomy
regenerative medicine
stem and regenerative adipose tissue cells
stem cells
stromal-vascular fraction
Статья
Обзор
Erectile Dysfunction C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Erectile Dysfunction etiology C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Erectile Dysfunction therapy C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Эректильная дисфункция C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Эректильная дисфункция этиология C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Эректильная дисфункция терапия C12.100.500.214 C12.100.875.486 C12.200.294.214 F03.835.400
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Male
Мужской
Penile Erection G08.686.784.717
Эрекция G08.686.784.717
Postoperative Complications therapy C23.550.767
Послеоперационные осложнения терапия C23.550.767
Prostatectomy adverse effects E04.950.774.860.625
Простатэктомия вредные воздействия E04.950.774.860.625
Prostatic Neoplasms surgery C04.588.945.440.770 C12.100.500.260.750 C12.100.500.565.625 C12.200.294.260.750 C12.200.294.565.625 C12.200.758.409.750 C12.900.619.750
Предстательной железы новообразования хирургия C04.588.945.440.770 C12.100.500.260.750 C12.100.500.565.625 C12.200.294.260.750 C12.200.294.565.625 C12.200.758.409.750 C12.900.619.750
Recovery of Function G16.757
Восстановление функций G16.757
Journal Article V02.600
Журнальная статья V02.600
Review V02.600.500 V02.912
Обзор V02.600.500 V02.912
Prostate cancer (PCa) is one of the most common maligmancies and causes of death among men. Radical prostatectomy (RP) is optimal and recommended treatment modality for localized prostate cancer. More than half of all men undergoing surgery experience problems with erectile function and existing treatments do not provide a positive effect. Thus, there is a need for new approaches to the restoration of erectile function in patients after RP. One of these is the use of cell technologies, namely the stromal-vascular fraction and autologous platelet-rich plasma. This review examines the results of preclinical and clinical studies investigating the efficacy and safety of these treatment options in erectile dysfunction.